You are here

Article Text

Article menu
Download PDFPDF
Letter
Do patients with severe oesophagitis need follow-up?
  1. Connor Cotton1,2,
  2. Tamara Glaister1,2,
  3. Julia F Simons1,
  4. Suneil A Raju1,2,
  5. John M Hebden1,2
  1. 1Academic Unit of Gastroenterology, Royal Hallamshire Hospital, Sheffield, UK
  2. 2Division of Clinical Medicine, Faculty of Medicine and Population Health, The University of Sheffield Medical School, Sheffield, UK
  1. Correspondence to Dr Connor Cotton; connor.cotton{at}nhs.net

https://doi.org/10.1136/flgastro-2024-102962

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the recent retrospective cohort study by Grant et al, ‘Tailoring follow-up endoscopy in patients with severe oesophagitis’,1 which reviewed the clinical utility of follow-up endoscopy in patients with severe oesophagitis. Current British Society of Gastroenterology (BSG) guidelines state that all patients with Los Angeles (LA) grade D oesophagitis should be biopsied and re-evaluated at 6 weeks to exclude dysplasia and malignancy following treatment with proton pump inhibitors.2 However, there is a paucity of data showing outcomes following repeat oesophagogastroduodenoscopy (OGD) in patients with grade D oesophagitis. We would like to share our results from a cohort study looking at the utility and pick-up rates of pathology in patients with severe oesophagitis to establish the clinical utility …

    View Full Text

    Footnotes

    • Contributors CC and SAR contributed to writing and editing. TG, JFS and SAR contributed to data collection. All authors contributed to data interpretation and analysis. JMH is the guarantor.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles